The MedTech C(D)MO market is growing at 8–9% per year. Roland Berger and William Blair reveal the winning framework and M&A investment guide.
What Indonesia's TKDN regulation demands from MNCs
By Yoshihiro Suwa and Lola Wijaya
Local content requirements are reshaping medical device market access
Success in Indonesia’s rapidly growing medical device market will hinge on compliance with the TKDN (Tingkat Komponen Dalam Negeri), or Domestic Content Level. To qualify for preferential treatment in public procurement, companies must achieve a TKDN score of at least 25%. However, this requires more than simply conducting final assembly or packaging locally. Manufacturers must also localize upstream activities, including raw material sourcing and product design. This shift means that traditional distributor-led business models may no longer be sufficient to compete in the market.
Localization: TKDN is shifting Indonesia from a distributor-led market towards full-scale localization.
Capability: Traditional distributors may fall short, making capable partners or in-house investment essential.
Timing: Local companies are seeking foreign partners, but the limited talent pool makes early action critical.
Public procurement raises the stakes for localization
The TKDN (Tingkat Komponen Dalam Negeri) is a framework that measures the domestic contribution of a product across materials and components, design and R&D, manufacturing, and packaging.
A separate measure, BMP, assesses a company’s wider contribution to the Indonesian economy and workforce.
The procurement thresholds have distinct implications. A TKDN score of at least 25% is the minimum threshold for eligibility, while a combined TKDN and BMP score of 40% or more can qualify a product for priority procurement. BMP can complement TKDN, but it does not replace the need to build local content.
The tiered procurement framework operates as follows:
- TKDN + BMP ≥ 40%: Priority procurement status, the preferred option when available
- TKDN ≥ 25% (standalone): Minimum threshold for public procurement eligibility
- Below 25%: Effectively excluded when compliant alternatives exist
- Not listed on e-Katalog (electronic catalog): No access to large-scale government procurement
"TKDN regulations have fundamentally transformed the Indonesian market. Whether companies are considering entering the market or are already established there, this is the biggest opportunity yet, and the key to success boils down to ‘acting quickly’"
That distinction matters in a market where public-sector purchasing accounts for approximately 64% of medical device demand. Procurement eligibility can therefore influence a manufacturer’s broader ability to establish a viable position in Indonesia, rather than simply determine access to one sales channel.
Localization ambitions determine the partner profile
Moving beyond assembly and packaging requires capabilities that a conventional distributor may not have. Manufacturers need to assess whether potential partners can provide production facilities, quality systems, supplier relationships, and, for higher localization targets, design or R&D capacity.
The operating model should follow the intended TKDN target. Local assembly and packaging may be an initial step, while local sourcing of components or materials can support higher scores. More ambitious targets may involve in-country design adaptation, compliance testing, or software development.
Timing and product focus shape the opportunity
Preparing local production takes time. Our analysis estimates that finding a suitable partner and reaching production readiness can take around two years.
Companies that delay beyond 2026 may have to wait until after 2030 for another meaningful opportunity to bring products to market locally.
In-vitro diagnostics, imaging and electronic medical equipment offer potential entry points for new market participants through manufacturing partnerships. By contrast, some mechanical medical devices and consumables are already dominated by local manufacturers, leaving less room for new entrants.
Localization options vary by segment. In diagnostics, local reagent production and instrument assembly can contribute to TKDN, while electronic equipment manufacturers may retain core technologies and localize assembly or housing.
The key is to work backwards from the target TKDN score and procurement objectives, aligning product priorities with partner capabilities, investment needs and timelines.
The full report explores these options and potential pathways in greater detail.
Sign up now to access the full report. You will also receive regular news and updates, delivered straight to your inbox.